2931 related articles for article (PubMed ID: 32286245)
1. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
[TBL] [Abstract][Full Text] [Related]
2. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
3. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
5. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
7. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
8. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis.
Ji P; Zhu J; Zhong Z; Li H; Pang J; Li B; Zhang J
Medicine (Baltimore); 2020 Nov; 99(47):e23315. PubMed ID: 33217868
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.
Lippi G; Plebani M; Henry BM
Clin Chim Acta; 2020 Jul; 506():145-148. PubMed ID: 32178975
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
[No Abstract] [Full Text] [Related]
11. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
[TBL] [Abstract][Full Text] [Related]
12. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
[No Abstract] [Full Text] [Related]
13. Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.
Castro VM; McCoy TH; Perlis RH
JAMA Netw Open; 2020 Oct; 3(10):e2023934. PubMed ID: 33125498
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.
Chen R; Sang L; Jiang M; Yang Z; Jia N; Fu W; Xie J; Guan W; Liang W; Ni Z; Hu Y; Liu L; Shan H; Lei C; Peng Y; Wei L; Liu Y; Hu Y; Peng P; Wang J; Liu J; Chen Z; Li G; Zheng Z; Qiu S; Luo J; Ye C; Zhu S; Zheng J; Zhang N; Li Y; He J; Li J; Li S; Zhong N;
J Allergy Clin Immunol; 2020 Jul; 146(1):89-100. PubMed ID: 32407836
[TBL] [Abstract][Full Text] [Related]
15. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
[TBL] [Abstract][Full Text] [Related]
17. Association of inflammatory markers with the severity of COVID-19: A meta-analysis.
Zeng F; Huang Y; Guo Y; Yin M; Chen X; Xiao L; Deng G
Int J Infect Dis; 2020 Jul; 96():467-474. PubMed ID: 32425643
[TBL] [Abstract][Full Text] [Related]
18. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
Chen X; Yan L; Fei Y; Zhang C
J Clin Lab Anal; 2020 Oct; 34(10):e23467. PubMed ID: 32656888
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19.
Qun S; Wang Y; Chen J; Huang X; Guo H; Lu Z; Wang J; Zheng C; Ma Y; Zhu Y; Xia D; Wang Y; He H; Wang Y; Fei M; Yin Y; Zheng M; Xu Y; Ge W; Hu F; Zhou J
Front Immunol; 2020; 11():2160. PubMed ID: 32983180
[TBL] [Abstract][Full Text] [Related]
20. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
